Literature DB >> 11535599

The roles of phosphatidylinositol 3-kinase and protein kinase Czeta for thrombopoietin-induced mitogen-activated protein kinase activation in primary murine megakaryocytes.

P Rojnuckarin1, Y Miyakawa, N E Fox, J Deou, G Daum, K Kaushansky.   

Abstract

Thrombopoietin (TPO) stimulates a network of intracellular signaling pathways that displays extensive cross-talk. We have demonstrated previously that the ERK/mitogen-activated protein kinase pathway is important for TPO-induced endomitosis in primary megakaryocytes (MKs). One known pathway by which TPO induces ERK activation is through the association of Shc with the penultimate phosphotyrosine within the TPO receptor, Mpl. However, several investigators found that the membrane-proximal half of the cytoplasmic domain of Mpl is sufficient to activate ERK in vitro and support base-line megakaryopoiesis in vivo. Using BaF3 cells expressing a truncated Mpl (T69Mpl) as a tool to identify non-Shc/Ras-dependent signaling pathways, we describe here novel mechanisms of TPO-induced ERK activation mediated, in part, by phosphoinositide 3-kinase (PI3K). Similar to cells expressing full-length receptor, PI3K was activated by its incorporation into a complex with IRS2 or Gab2. Furthermore, the MEK-phosphorylating activity of protein kinase Czeta (PKCzeta) was also enhanced after TPO stimulation of T69Mpl, contributing to ERK activity. PKCzeta and PI3K also contribute to TPO-induced ERK activation in MKs, confirming their physiological relevance. Like in BaF3 cells, a TPO-induced signaling complex containing p85PI3K is detectable in MKs expressing T61Mpl and is probably responsible for PI3K activation. These data demonstrate a novel role of PI3K and PKCzeta in steady-state megakaryopoiesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11535599     DOI: 10.1074/jbc.M106508200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  The molecular mechanisms that control thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

2.  The additive effects of combined murine nuclear migration protein with murine thrombopoietin in vitro and in vivo on normal and myelosuppressed mice.

Authors:  Xiao-Yu Duan; Y Yang; Qing Zhang; Yi-Chen Ge; Peilin Xu
Journal:  Int J Hematol       Date:  2011-06-07       Impact factor: 2.490

3.  Beta2-integrin-mediated adhesion and intracellular Ca2+ release in human eosinophils.

Authors:  Jennifer L Bankers-Fulbright; Kathleen R Bartemes; Gail M Kephart; Hirohito Kita; Scott M O'Grady
Journal:  J Membr Biol       Date:  2009-03-17       Impact factor: 1.843

Review 4.  Thrombopoietin in normal and neoplastic stem cell development.

Authors:  Kenneth Kaushansky; Helen M Ranney
Journal:  Best Pract Res Clin Haematol       Date:  2009-12       Impact factor: 3.020

5.  Gab adapter proteins as therapeutic targets for hematologic disease.

Authors:  Sheetal Verma; Tamisha Vaughan; Kevin D Bunting
Journal:  Adv Hematol       Date:  2011-12-14

6.  Analysis of 20alpha-hydroxysteroid dehydrogenase expression in the corpus luteum of the buffalo cow: effect of prostaglandin F2-alpha treatment on circulating 20alpha-hydroxyprogesterone levels.

Authors:  Tripathy Sudeshna; Kumarasamy Anand; Rudraiah Medhamurthy
Journal:  Reprod Biol Endocrinol       Date:  2013-12-11       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.